Via practica 4/2022
Non-muscle invasive bladder cancer
Non-muscle invasive bladder cancer comprises about 70 % of all newly diagnosed bladder cancer, and includes tumors with stage Ta, T1 and carcinoma in situ. It is a heterogeneous group of diseases differing mainly due to the variability of recurrence. Clinical management and treatment should not be standardised, but adapted to the risk groups.
Keywords: tumor, urinary bladder, classification, therapy
